The impact of body mass index (BMI) on the progression-free survival of CDK4/6 inhibitors in metastatic breast cancer patients (MBC)

Basit Öğe Kaydı
dc.contributor.authorArtac, M.
dc.contributor.authorCaglayan, D.
dc.contributor.authorKocak, M. Z.
dc.contributor.authorGeredeli, C.
dc.contributor.authorTatli, A. M.
dc.contributor.authorGoksu, S. Sezgin
dc.contributor.authorImaz, M. Karakurt Ery
dc.date.accessioned2024-02-23T14:02:06Z
dc.date.available2024-02-23T14:02:06Z
dc.date.issued2022
dc.departmentNEÜen_US
dc.descriptionAnnual Meeting of the European-Society-for-Medical-Oncology (ESMO) -- SEP 09-13, 2022 -- ELECTR NETWORKen_US
dc.description.abstract[Abstract Not Availabe]en_US
dc.description.sponsorshipEuropean Soc Med Oncolen_US
dc.identifier.doi10.1016/j.annonc.2022.07.274
dc.identifier.endpageS645en_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.issue7en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpageS644en_US
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2022.07.274
dc.identifier.urihttps://hdl.handle.net/20.500.12452/11582
dc.identifier.volume33en_US
dc.identifier.wosWOS:000866211600229en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofAnnals Of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[Keyword Not Available]en_US
dc.titleThe impact of body mass index (BMI) on the progression-free survival of CDK4/6 inhibitors in metastatic breast cancer patients (MBC)en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu